Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome

Human Mutation

Volumn 20, Issue 6, 2002, Pages 460-462

  Sodha, Nayanta ^a   Houlston, Richard S ^b   Bullock, Sarah ^b   Yuille, Martin A ^b   Chu, Carol ^c   Turner, Gwen ^c   Eeles, Rosalind A ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER GENETICS; CHEK2 GENE; FAMILIAL CANCER; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LETTER; PEDIGREE ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL;

FAMILY HEALTH; FEMALE; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; PEDIGREE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 18744372122     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10136     Document Type: Letter

References (10)

1. Allinen M, Huusko P, Mantyniemi S, Launonen V, Winqvist R. 2001. Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br J Cancer 85:209-212.
2. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Iselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA. 1999. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528-2531.
3. Birch JM. 1994. Li-Fraumeni syndrome. Eur J Cancer 30A:1935-1941.
4. Birch J, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Osborne BE, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD, Santibanes-Koref ME 1994. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298-1304.
5. Bougeard G, Limacher JM, Martin C, Charbonnier F, Killian A, Delattre O, Longy M, Joveaux P, Fricker JP, Stoppa-Lyonnet D, Flaman JM, Frebourg T 2001. Detection of 11 germline inactivating p53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni like syndrome. J Med Genet 38:253-257.
6. Lee SB, Kim SH, Bell DW, Wahrer CR, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, Harlow E, Haber DA. 2001. Destabililization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res. 61:8062-8067.
7. Meijers-Heijboer H, Van den Ouweland A, Klijn J, Wasielewski M, De Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, Monique Van Veghel-Plandsoen M, Elstrodt F, Van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton DF, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles RA, Evans DG, Houlston RS, Murday VA, Narod S, Peretz T, Peto J, Tonin P, Devilee P, Szabo C, Goldgar D, Futrea PA, Nathanson KL, Weber BL, Rahman N, Stratton MR. 2002. CHEK2 1100delC is a low penetrance familial breast cancer susceptibility allele except in BRCA1 and BRCA2 mutation carriers. Nat Genet 31:55-59.
8. Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J, Eeles RA. 2002. A robust method for detecting CHK2/ RAD53 mutations in genomic DNA. Hum Mutat 19:173-177.
9. Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K, Nevanlinna H. 2001. P53, CHK2 and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718-5722.
10. Varley JM, Evans DG, Birch JM. 1997. Li-Fraumeni syndrome: A molecular and clinical review. Br J Cancer 7:1-14.